145 related articles for article (PubMed ID: 3706365)
1. Outpatient conversion of treatment to potassium-sparing diuretics.
Ridgeway NA; Ginn DR; Alley K
Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
[TBL] [Abstract][Full Text] [Related]
2. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
[TBL] [Abstract][Full Text] [Related]
3. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
[TBL] [Abstract][Full Text] [Related]
4. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
Blume CD; Williams RL
Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
[TBL] [Abstract][Full Text] [Related]
6. Plasma electrolytes in elderly patients taking fixed combination diuretics.
Bayer AJ; Farag R; Browne S; Pathy MS
Postgrad Med J; 1986 Mar; 62(725):159-62. PubMed ID: 3714599
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL; Clark T; Blume CD
Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
[TBL] [Abstract][Full Text] [Related]
9. [Comparative evaluation of the anti-hypertensive effect of moduretic and thiazides].
Rosenfeld JB
Schweiz Med Wochenschr; 1980 Oct; 110(41):1498-501. PubMed ID: 7423177
[TBL] [Abstract][Full Text] [Related]
10. Serum potassium concentrations after initiation of captopril therapy.
Schuna AA; Schmidt GR; Pitterle ME
Clin Pharm; 1986 Nov; 5(11):920-3. PubMed ID: 3536269
[No Abstract] [Full Text] [Related]
11. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide.
Davidov ME; Becker FE; Hollifield JW
Am J Med; 1987 Mar; 82(3A):48-51. PubMed ID: 3565425
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
Seedat YK; Naidoo DN
S Afr Med J; 1973 Jul; 47(28):1219-21. PubMed ID: 4721040
[No Abstract] [Full Text] [Related]
13. Biochemical changes in black and Indian hypertensive patients on diuretic therapy.
Bhigjee AI; Seedat YK; Hoosen S; Neerahoo RM; Naidoo K
S Afr Med J; 1983 Dec; 64(25):969-72. PubMed ID: 6648735
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
Jaffé G; Grimshaw JJ; Vallé-Jones JC; Warnock JM
Practitioner; 1982 Feb; 226(1364):355-8. PubMed ID: 7088834
[No Abstract] [Full Text] [Related]
15. Essential hypertension: new insights and controversies in treatment with diuretics.
Houston MC; Johnston PE
South Med J; 1986 Aug; 79(8):984-90. PubMed ID: 3526575
[No Abstract] [Full Text] [Related]
16. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
Casner PR; Dillon KR
J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
[TBL] [Abstract][Full Text] [Related]
17. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Damian DJ; McNamee R; Carr M
BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of moduretic in the treatment of arterial hypertension.
Salako LA; Falase AO
Niger Med J; 1973 Jul; 3(3):150-5. PubMed ID: 16366351
[No Abstract] [Full Text] [Related]
19. Biochemical changes during moduretic treatment of hypertension in African patients.
Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Salako LA
Kobe J Med Sci; 1995 Aug; 41(4):83-93. PubMed ID: 8904160
[No Abstract] [Full Text] [Related]
20. Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
Verho M; Irmisch R; de Looze S; Rangoonwala B
Int J Clin Pharmacol Res; 1987; 7(6):433-42. PubMed ID: 3440634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
